NCT00643669View on ClinicalTrials.gov

24 Hour IOP Lowering Efficacy of AL-3789

PHASE2CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

April 30, 2008

Conditions

Open-angle Glaucoma

Interventions

DRUG

AL-3789 Sterile Suspension

Single administration by anterior juxtascleral depot

Trial Locations (1)

90301

Inglewood, Inglewood

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY

NCT00643669 - 24 Hour IOP Lowering Efficacy of AL-3789 | Biotech Hunter | Biotech Hunter